BALTIMORE, MD—April 30, 2013—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), has partnered with the American Association of Diabetes Educators (AADE) to provide complimentary CME/CE/CPE to clinicians who care for patients with type 2 diabetes.

Patient-Clinician Perspectives on Insulin Therapy and the Role of Insulin Pens in Type 2 Diabetes: Current Evidence and Frontline Discussions

Approximately 8.3% of the US population is living with diabetes. Type 2 diabetes is a major cause of heart disease and stroke and can lead to kidney failure, lower-limb amputations, and blindness in patients living with the disease. Recent findings provide compelling evidence that intensive treatment of this condition and its known risk factors can significantly decrease the development/progression of diabetes-related complications.

Achieving adequate glycemic control is one of the cornerstones of preventing diabetes-related complications and early death, and the participation of both clinicians and patients in the management of this progressive disease is essential for success. Evidence demonstrates the use of insulin pens for obtaining adequate glycemic control may provide tangible clinical benefits over the traditional vial and syringe method of administration, yet clinicians and patients are often reluctant to begin insulin therapy.

This comprehensive educational activity offers a unique view on initiating insulin and using insulin pens in the management of type 2 diabetes by incorporating frontline perspectives and key teaching points from nationally recognized diabetes experts, certified diabetes educators, and patients.

Participants of the activity will learn strategies for supporting the appropriate implementation of insulin pens into practice, fostering effective communication to help overcome psychological insulin resistance, and reinforcing patient and physician acceptance of this treatment modality.

"Educational interventions that focus on strengthening patient-provider collaboration and shared decision making play an essential role in empowering patients to manage their disease and are important tools to overcome clinical challenges and improve patient adherence to therapy and outcomes," said William A. Mencia, MD, CCMEP, Vice President of Education and Medical Affairs at Med-IQ. "Med-IQ is pleased to be collaborating with the AADE to provide this continuing education activity to clinicians who manage the approximately 26 million people living with diabetes in the US."

Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses. Provider approved by the California Board of Registered Nursing, provider number CEP 14745, for 1.0 contact hour.

Registered Dietitians/Dietetic Technicians: The American Association of Diabetes Educators, (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.0 continuing professional education units (CPEUs) for completion of this program. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

Others: Nurse practitioners, physician assistants, certified diabetes educators, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

This activity is provided by Med-IQ in collaboration with the American Association of Diabetes Educators (AADE).

This activity is supported by an educational grant from Sanofi-aventis U.S. Inc., A SANOFI COMPANY.

For more information, call (toll-free) 866 858 7434, e-mail info@med-iq.com, or visit www.Med-IQ.com/a658.

About AADE

Founded in 1973, AADE is a multi-disciplinary professional membership organization dedicated to improving diabetes care through education. With more than 13,000 professional members including nurses, dietitians, pharmacists, and others, AADE has a vast network of practitioners involved in the daily treatment of diabetes patients. To learn more, visit www.diabeteseducator.org.


About Med-IQ

Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.

Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.


For more information, contact:

Catherine B. Mullaney, MHA
Vice President, Educational Partnerships
Med-IQ
443 543 5101
info@med-iq.com